Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4178 - Association between systemic inflammation and symptoms in advanced cancer patients

Date

10 Sep 2017

Session

Poster display session

Presenters

David Viñal Lozano

Citation

Annals of Oncology (2017) 28 (suppl_5): v543-v567. 10.1093/annonc/mdx388

Authors

D. Viñal Lozano1, A. Alonso-Babarro2, Y. Vilches-Aguirre2, L. Diez-Porres2, M. Varela-Cerdeira2, J. Villamayor Sanchez1, L. Gutierrez Sainz1, R. Madero-Jarabo2

Author affiliations

  • 1 Medical Oncology, Hospital Universitario La Paz, 28046 - Madrid/ES
  • 2 Acute Palliative Care Unit, Hospital Universitario La Paz, 28046 - Madrid/ES
More

Resources

Abstract 4178

Background

There is growing evidence relating inflammation as a prognostic factor in cancer patients. Previous reports have found a small but significant association between systemic inflammation and symptoms in advanced cancer patients. The aim of this study was to analyse the relationship between systemic inflammatory response markers with the symptoms and performance status of advanced cancer patients that have been admitted to an Acute Palliative Care Unit (PCU).

Methods

We conducted an observational study including all cancer patients admitted in the PCU between January 2012 and April 2015. We performed a correlation analysis (spearman’s rho) between serum C-reactive-protein (CRP), the modified Glasgow Prognostic Score (mGPS) and Neutrophil-to Lymphocyte Ratio (NLR) with patients symptoms recorded as the Edmonton Symptom Assessment Sytem (ESAS) and performance status recorded as Eastern Cooperative Oncology Group (ECOG), Barthel Index and Palliative Performance Scale (PPS). All data were collected within the first two days of admission.

Results

Data of 951 patients were available. The median survival was 17 days. CRP was significantly correlated with ECOG (ρ:0.180, P:0.000), dyspnoea (ρ:0.079, p:0.019), fatigue (ρ:0.162, p 

Conclusions

There is a small but significant correlation between systemic inflammation and symptoms. Further studies are needed to confirm the results and to test this relation in earlier phases of the disease.

Clinical trial identification

Legal entity responsible for the study

Hospital Universitario La Paz

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.